The Autumn Wind

U.S. canna looks ahead.

Daily Recap

The majority of adults who consume cannabis to treat a medical condition say that it improves their symptoms, according to survey data published in the Harm Reduction Journal.

Ninety-seven percent of those surveyed said that their condition “was a little, much, or very much better since starting medical cannabis,” a finding that is consistent with the results of prior surveys and observational trials.

Ratchet Up

More than nine in ten nursing students believe that patients should be legally able to access medical cannabis, but few report receiving sufficient training while in medical school, according to survey data published in the journal Nurse Practitioner.

Researchers in Boston surveyed over 100 nurse practitioner (NP) students and 94% of the respondents said that “medical marijuana should be legalized in all US states.”

Individual Rights

A federal appeals court panel ruled in favor of a Texas woman whom judges described as a “non-violent, marijuana smoking gunowner,” affirming a lower court’s ruling that federal charges filed against the woman for owning a firearm as a cannabis user are unconstitutional.

“The short of it is that our history and tradition may support some limits on a presently intoxicated person’s right to carry a weapon,” the court wrote in the new opinion, “but they do not support disarming a sober person based solely on past substance usage.”

Perspective Check

The news this week that the DEA scheduled an ALJ hearing for December 2nd was widely reported by many the media as a “delay.” While markets were upset that the rescheduling process won’t be done by the election, this step was designed to make the final rule more durable and less political.

Stocks & Stuff

The one year anniversary of the HHS leak arrived the morning after former President Donald Trump hinted that he might vote in favor of Florida’s A4 (abortion), offering a further read-through on A3 (adult-use cannabis), as well as Schedule III.

U.S. cannabis ETF MSOS finished +3% for the session, but lost 12% on the week.

Below, we’ll top-line the landscape, unpack the week that was, explore what changed in the last year, dig deeper on a potential winner in the Cali carnage and otherwise say goodbye to Hollywood summer ahead of what promises to be an active Autumn.

All that and more, just scroll down.

SPY 0.00%↑ QQQ 0.00%↑ IWM 0.00%↑ MSOS 0.00%↑ PT: $48M

Top Stories